Markets Brief: US Interest Rate Cut Odds Shorten

Plus: Fed decision looms, more inflation data and when to sell stocks.

Dan Kemp 16 December, 2024 | 12:03PM
Facebook Twitter LinkedIn

Illustration on binoculars with graphical elements and time series graph in the background

Mixed Valuation for Consumer Stocks

US equities fell 0.8% last week, with mid and small-cap stocks leading the decline, while large companies declined the least. At a sector level, only communications services and consumer cyclical rose with each dominated by a single stock. Alphabet GOOG which accounts for 38% of the communication services sector was up 8.4% and Tesla TSLA, the second largest consumer cyclical stock rose 12.1%. Tesla’s stock price is now more than double Morningstar’s estimate of its fair value while Alphabet remains undervalued. This demonstrates the considerable variation in opportunities at a company level despite the sharp rise in the index over 2024. You can dig into these disparities in Morningstar’s Market valuation view here.

Is the Stock Market Overvalued?

Following the sharp rise in stock prices since the election more commentators are warning about high valuations prompting the question how should investors respond? The first thing to remember is that although high valuations are an indicator of lower future returns, they are a poor timing indicator. Investor sentiment can drive market prices to more extreme levels than most think possible. Significantly reducing equity exposure in your portfolio is therefore may therefore lead to regret and in the worst cases the re-purchase securities at a higher price. Equally, ignoring valuations can lead to permanent capital losses which could prevent you from reaching your financial goals.

Investor Time Horizon Makes a Huge Difference

Any response should be considered in the context of the purpose of your portfolio. The right response for a person with 20 years of work left may be different to someone already in retirement. It is for this reason that we treat these situations separately in our 2025 outlook.

For most investors, the first response to a concentrated rise in prices should be to rebalance the portfolio back to its original target weights as this will reduce excess exposure to assets that have risen strongly and add to those that have lagged. For those that want to go further, seeking underpriced parts of the market can be a good alternative to selling stocks. This will enable you to remain engaged with stocks which are the engine of long-term returns while marginally increasing those expected returns and reducing the probability of a sharp fall.

Selling Stocks Slowly

If you do want to reduce your equity exposure, do so gradually rather than making a precipitous adjustment as the catalyst for a change in market direction is typically only discernible with the benefit of hindsight. But bear in mind that most investors find it difficult to purchase stocks when the prospects are bleak and the valuations attractive. Selling to avoid a near-term decline may therefore impair returns over the long term.

How Many Fed Rate Cuts in 2025?

The latest CPI data was in line with expectations, increasing the probability of a 0.25 percentage point cut in interest rates when the Federal Reserve’s Open Market Committee (FOMC) concludes its meeting on Wednesday. While that decision will make the headlines, market commentators will be more interested in the ‘dot plots’ that indicate the interest rate expectations of individual members of the FOMC as this may challenge current thinking on future interest rate cuts. At present, two further interest rate cuts are priced into market expectations for 2025. If the FOMC members were to signal a different outcome, there is likely to be some volatility in asset prices. You can get more detail on the inflation data last week from Bella Albrecht here.

Up Next: PCE Data

Alongside the FOMC meeting, there is a deluge of economic data this week, including retail sales, the second revision to third quarter GDP and more inflation data in the form of the Personal Consumption Expenditures index on Friday. While each of these announcements could cause price volatility at any time in the year, the onset of the holidays increases the probability of this outcome as the number of active participants in the market is lower. You can keep up to date with all of the economic data releases on this calendar.

Highlights of This Week’s Market and Investing Events

Monday, Dec. 16: Purchasing Managers Index Composite

Tuesday, Dec. 17: Retail Sales, Capacity Utilization, Industrial Production, Business Inventories

Wednesday, Dec. 18: New Residential Construction, Federal Open Market Committee decision on interest rates

Thursday, Dec. 19: Initial Unemployment Insurance Claims, Federal Reserve Bank of Philadelphia Index, Existing Home Sales, Leading Indicators, earnings from Nike NKE

Friday, Dec. 20: Personal Income and Outlays report

Market Performance - Trading Week Ended Dec. 13

The Morningstar US Market Index fell 0.9%.

The best-performing sectors were consumer cyclicals, up 1.1%, and communication services, up 0.6%.

The worst-performing sector was basic materials, down 3.2%.

Yields on 10-year US Treasury notes rose to 4.40% from 4.15%.

West Texas Intermediate crude prices fell 0.1% to $71.06 per barrel.

Of the 877 US-listed companies covered by Morningstar, 245, or 28%, were up, one was unchanged, and 631, or 72%, were down.

Best-Performing Stocks

The RealReal REAL, Broadcom AVGO, Walgreens Boots Alliance WBA, Restoration Hardware RH, and Warner Bros. Discovery WBD were the top performers among US-listed stocks covered by Morningstar analysts.

The RealReal performed best, gaining 36.5%, and it’s up 254.4% over the last three months. The no-moat company, which carries a 1-star rating, is up 292.0% over the last 12 months. The stock finished the week at $8.80, trading at a 290.7% premium to its fair value estimate of $2.25 per share.

Broadcom was the second-best-performing stock, with a 25.2% return. The 2-star stock has gained 10.1% over the last three months. Shares in the wide-moat company are up 70.4% over the last 12 months. Broadcom stock finished the week at $224.8, trading at an 18.3% premium to its fair value estimate of $190 per share.

Ranking third was no-moat Walgreens Boots Alliance. The 5-star stock rose 21.4%, gained 12.9% over the last three months, and lost 53.2% over the past year. At the end of the week, Walgreens stock was trading at $10.40, a 48% discount to its fair value estimate of $20 per share.

Restoration Hardware stock rose 18.6%. The no-moat company has gained 48.7% over the past three months and is up 50.7% over the past 12 months. The 2-star stock finished the week at $446 per share, a 48.7% premium to its fair value estimate of $300 per share.

The fifth-best-performing stock for the week was Warner Bros. Discovery, with a gain of 13.2%. The 4-star stock has risen 63.1% and it’s up 11.2% over the last 12 months. Warner Bros. Discovery closed the week at $12.10, a 39.6% discount to its fair value estimate of $20 per share.

Line chart showing 1-week returns for the five top-performing stocks. - graphic - Tom Lauricella - © Copyright 2024 Morningstar, Inc. All rights reserved.

Worst-Performing Stocks

MongoDB MDB, CRISPR Therapeutics CRSP, Adobe ADBE, Sirius XM Holdings SIRI, and Ferguson Enterprises FERG performed worst among US-listed stocks covered by Morningstar analysts.

MongoDB was the worst-performing stock of the week, falling 22.2%. This 3-star, no-moat company has increased 2.2% over the last three months and 26.6% over the past 12 months. The stock ended the week at $267.20, trading at a 7.9% discount to its fair value estimate of $290 per share.

CRISPR Therapeutics took the second spot, with a 16.3% price decline this week. The no-moat company, rated 5 stars, has fallen 1.1% in the past three months and increased by 21.9% over the last year. Closing at $43.80, the stock trades at a 58.7% discount to its fair value estimate of $106 per share.

Adobe came in third, experiencing a 15.8% drop this week. This 4-star, wide-moat company is up 19.1% in the last three months and 25.1% over the past year. The stock finished the week at $465.70, trading at a 21.1% discount to its fair value estimate of $590 per share.

Next up is Sirius XM Holdings, which saw its stock price fall by 14.8% this week. The no-moat company, which has a 3-star rating, has dropped 1.7% over the past three months and is up 51.2% over the last year. At $24.10, the stock trades at a 19.6% discount to its fair value estimate of $30 per share.

Ferguson Enterprises rounds out the list, with its stock declining by 13.6% this week. Rated 2 stars, this narrow-moat company has increased 0.5% over the past three months and 5.8% over the last 12. The stock closed the week at $187.50, trading at an 11.6% premium to its fair value estimate of $168 per share.

Line chart showing 1-week returns for the five worst-performing stocks. - graphic - Tom Lauricella - © Copyright 2024 Morningstar, Inc. All rights reserved.


This article was generated with the help of automation and reviewed by Morningstar editors. Learn more about Morningstar’s use of automation.

The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar's editorial policies.

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

About Author

Dan Kemp

Dan Kemp  is Chief Investment Officer, Morningstar Investment Management EMEA

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures